BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Prognosis
9 results:

  • 1. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
    Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
    BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]    [Full Text] [Related]  

  • 3. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
    Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
    Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Establishment and validation of prognostic nomograms integrating histopathological features in patients with endocervical adenocarcinoma.
    Luo RZ; Yang X; Zhang SW; Liu LL
    J Clin Pathol; 2023 Nov; 76(11):747-752. PubMed ID: 35999033
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
    Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
    Zheng F; Yu H
    Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer.
    Sun H; Xin J; Lu Z; Wang N; Liu N; Guo Q
    Cell Physiol Biochem; 2013; 32(5):1528-40. PubMed ID: 24335178
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study.
    Seebacher V; Schmid M; Polterauer S; Hefler-Frischmuth K; Leipold H; Concin N; Reinthaller A; Hefler L
    BMC Cancer; 2009 Dec; 9():460. PubMed ID: 20028502
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors.
    Kucera H; Vavra N; Weghaupt K
    Gynecol Oncol; 1990 Jul; 38(1):99-104. PubMed ID: 2191908
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.